Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Al Sadi, Rana ^a,b   Ye, Dongmei ^a   Boivin, Michel ^a   Guo, Shuhong ^a,b   Hashimi, Mariam ^a   Ereifej, Lisa ^a   Ma, Thomas Y ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 2; DNA; INTERLEUKIN 6; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CLAUDIN 2 GENE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERMEABILITY BARRIER; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TIGHT JUNCTION; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; INTESTINE MUCOSA; INTRACELLULAR SPACE; METABOLISM; PERMEABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CACO-2 CELLS; CLAUDIN-2; HUMANS; INTERLEUKIN-6; INTESTINAL MUCOSA; INTRACELLULAR SPACE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MICE; PERMEABILITY; TIGHT JUNCTIONS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 84899722895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085345     Document Type: Article

References (43)

1. Ma TY, Anderson JM (2012) Tight junctions and the intestinal barrier. In: Physiology of the Gastrointestinal Tract, Burlington, MA: Elsevier Academic Press.
2. Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809.
3. Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, et al. (2008) Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 22: 146-158.
4. Hollander D (1999) Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1: 410-416.
5. Al-Sadi R, Ye D, Dokladny K, Ma TY (2008) Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 180: 5653-5661.
6. Al-Sadi RM, Ma TY (2007) IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178: 4641-4649. (Pubitemid 46492417)
7. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, et al. (2004) TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286: G367-376. (Pubitemid 38250308)
8. Nusrat A, Turner JR, Madara JL (2000) Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279: G851-857.
9. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, et al. (1997) Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 273: C1378-1385.
10. Mazzon E, Puzzolo D, Caputi AP, Cuzzocrea S (2002) Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol Med 8: 353-366. (Pubitemid 35346215)
11. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang MS, et al. Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. Am J Physiol Lung Cell Mol Physiol 304: L863-872.
12. Severson EA, Parkos CA (2009) Mechanisms of outside-in signaling at the tight junction by junctional adhesion molecule A. Ann N Y Acad Sci 1165: 10-18.
13. Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, et al. (2007) JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 204: 3067-3076.
14. Heller F, Florian P, Bojarski C, Richter J, Christ M, et al. (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564. (Pubitemid 41096643)
15. Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 304: G970-979.
16. Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, et al. (2001) Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 160: 345-350. (Pubitemid 32449145)
17. Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, et al. (2001) Increased expression of IL-16 in inflammatory bowel disease. Gut 48: 326-332. (Pubitemid 32269559)
18. Radford-Smith G, Jewell DP (1996) Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 10: 151-164. (Pubitemid 26125752)
19. Ito H (2005) Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol 40 Suppl 16: 32-34.
20. van Hogezand RA, Verspaget HW (1996) Selective immunomodulation in patients with inflammatory bowel disease-future therapy or reality? Neth J Med 48: 64-67.
21. Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, et al. (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, doubleblind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46: 3143-3150. (Pubitemid 35453522)
22. Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, et al. (2003) IL-6 induces NF-kappa B activation in the intestinal epithelia. J Immunol 171: 3194-3201. (Pubitemid 37093545)
23. Rollwagen FM, Yu ZY, Li YY, Pacheco ND (1998) IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol 89: 205-213. (Pubitemid 28565106)
24. Suzuki T, Yoshinaga N, Tanabe S (2011) Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286: 31263-31271.
25. Tazuke Y, Drongowski RA, Teitelbaum DH, Coran AG (2003) Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model. Pediatr Surg Int 19: 321-325. (Pubitemid 37046190)
26. Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C, et al. (2007) Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 292: G590-598.
27. Ye D, Ma I, Ma TY (2006) Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290: G496-504.
28. Ye D, Ma TY (2008) Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 12: 1331-1346.
29. Al-Sadi R, Boivin M, Ma T (2009) Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci 14: 2765-2778.
30. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, et al. (2005) Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 115: 2702-2715. (Pubitemid 41434398)
31. Ye D, Guo S, Al-Sadi R, Ma TY MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141: 1323-1333.
32. Al-Sadi R, Khatib K, Guo S, Ye D, Youssef M, et al. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 300: G1054-1064.
33. Van Itallie CM, Holmes J, Bridges A, Gookin JL, Coccaro MR, et al. (2008) The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 121: 298-305. (Pubitemid 351356701)
34. Wang Q, Guo XL, Wells-Byrum D, Noel G, Pritts TA, et al. (2008) Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells. Shock 29: 531-537. (Pubitemid 351416808)
35. Garat C, Arend WP (2003) Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 23: 31-40. (Pubitemid 36937198)
36. Ma TY, Hoa NT, Tran DD, Bui V, Pedram A, et al. (2000) Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am J Physiol Gastrointest Liver Physiol 279: G875-885.
37. Hershko DD, Robb BW, Luo G, Hasselgren PO (2002) Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 283: R1140-1148. (Pubitemid 35216988)
38. Hungness ES, Pritts TA, Luo GJ, Sun X, Penner CG, et al. (2000) The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1beta-stimulated human enterocytes. Shock 14: 386-391.
39. Pallua N, Low JF, von Heimburg D (2003) Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and antisoluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 31: 1495-1501. (Pubitemid 36583865)
40. Schluter B, Konig B, Bergmann U, Muller FE, Konig W (1991) Interleukin 6-a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 31: 1663-1670.
41. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, et al. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215: 356-362.
42. Wang L, Srinivasan S, Theiss AL, Merlin D, Sitaraman SV (2007) Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations. J Biol Chem 282: 8219-8227. (Pubitemid 47093611)
43. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, et al. (2003) IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285: G621-629. (Pubitemid 37021822) Diseases